GCP
BDSX icon

GSA Capital Partners’s Biodesix BDSX Stock Holding History

GSA Capital Partners’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
46,989
+7,583
+19% +$112K 0.07% 468
2026
Q1 		$571K Sell
39,406
-25,077
-39% -$311K 0.04% 828
2025
Q4 		$438K Buy
64,483
+16,141
+33% +$119K 0.04% 909
2025
Q3 		$365K Buy
48,342
+1,772
+4% +$13.6K 0.03% 1078
2025
Q2 		$263K Buy
46,570
+44,903
+2,694% +$363K 0.02% 1340
2025
Q1 		$21K Buy
+1,667
New +$32K ﹤0.01% 1583

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

GSA Capital Partners's BDSX Position: Q2 2026 in Review

GSA Capital Partners increased its Biodesix (BDSX) stake by 19% in Q2 2026, buying an estimated $112K and bringing the position to 46,989 shares worth $1.06M. The position accounts for 0.07% of the portfolio, ranked #468.

GSA Capital Partners first reported a position in BDSX in Q1 2025 and has held it in 6 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • GSA Capital Partners held 46,989 shares of Biodesix worth $1.06M as of Q2 2026.
  • GSA Capital Partners bought 7,583 Biodesix shares in Q2 2026, an estimated $112K.
  • Biodesix made up 0.07% of GSA Capital Partners's portfolio in Q2 2026, its #468 holding.
  • GSA Capital Partners first reported a position in Biodesix in Q1 2025 and has held it in 6 quarters since.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.